基尿素可降低患有状细胞贫血的儿童中风风险:系统性审查和元分析
Emmanuela E Ambrose1, Paul Alikado Sabuni2, Don P Jason Iii3
1Department of Pediatrics and Child Health, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Blood global hematology
|December 24, 2025
概括
氨酸有效降低患有状细胞贫血 (SCA) 的儿童中风风险,通过降低异常血流速度. 这种治疗是一种可行的输血替代方案,特别是在资源有限的地区.
科学领域:
- 儿科血液学 儿科血液学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞贫血 (SCA) 是一种导致儿童中风的遗传性疾病.
- 体多普勒 (TCD) 超声波评估SCA患者中风风险.
- 目前的中风预防包括输血,在资源有限的环境中存在局限性.
研究的目的:
- 系统地审查氧尿素在降低SCA儿童TCD速度和中风风险方面的有效性.
- 为了澄清酸对TCD速度的影响的影响的大小和持续时间.
主要方法:
- 在五个主要医疗数据库中对潜在的临床试验进行了系统审查.
- 包括注册患有SCA的儿童的试验,使用TCD查,并在氧尿素治疗期间收集串行TCD速度和中风发病率数据.
- 分析了涉及592名参与者的13项试验的数据.
主要成果:
- 在0.5至2.6岁期间,基尿素显著降低了TCD平均速度-30cm/s,在大多数儿童中正常化.
- 脑卒中发病率很低 (0.52-1.92每100个患者年),仅发生在持续高TCD值 (>200厘米/秒) 的患者中.
- 基尿素在降低TCD速度和相关中风风险方面表现出有效性.
结论:
- 基尿素是通过降低TCD速度来减轻儿科SCA中风风险的有效策略.
- 它为输血提供了一种可行的替代方案,在资源有限的医疗机构中尤其有益.
- 进一步的研究是有必要的,以优化剂量,评估长期的安全性,并评估在不同的人群中全面的好处.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
171
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
01:29Drug Dosing: Infants and Children
229
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
229
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
225
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
242
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
242
01:11Renal Failure: Dose Adjustments
401
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
401